| RS1391287100 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS139128953 |
GJA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculodentodigital dysplasia, Syndactyly type 3 |
| RS139129327 |
EVC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1391295040 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS139129900 |
HEXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Sandhoff disease, Inborn genetic diseases |
| RS139130590 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Junctional epidermolysis bullosa with pyloric atresia |
| RS139130605 |
MYH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, proximal |
| RS139131485 |
DNAAF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 19, Multiple sclerosis |
| RS1391324814 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS139132568 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal recessive nonsyndromic hearing loss 21 |
| RS1391326211 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS139133094 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1391332906 |
TMPRSS3
|
Health Risk |
Likely pathogenic |
— |
| RS1391335025 |
RPGRIP1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 6, Leber congenital amaurosis 6 |
| RS139134468 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, CTNNA1-related disorder |
| RS139134591 |
COLGALT1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139134727 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS139135254 |
ABHD12
|
Health Risk |
Conflicting classifications of pathogenicity |
ABHD12-related disorder, ABHD12-related disorder |
| RS1391355304 |
MSH3
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 4, Familial adenomatous polyposis 4 |
| RS139135606 |
RAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1391365292 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1391369844 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1391372707 |
NEB
|
Health Risk |
Pathogenic |
— |
| RS1391374865 |
KIF12
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS139137932 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS139138043 |
LTBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma |
| RS139139263 |
DMXL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139139296 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS139139350 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Transient Neonatal Diabetes, Recessive |
| RS139139859 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Arrhythmogenic right ventricular dysplasia 9 |
| RS1391401672 |
STAT2
|
Health Risk |
Pathogenic |
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection |
| RS139141291 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS139141519 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, VCAN-related disorder |
| RS1391416524 |
IDH3A
|
Health Risk |
Pathogenic |
— |
| RS1391418639 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS139142141 |
ZNF423
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 14, Nephronophthisis 14 |
| RS139142520 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hypersulfaturia |
| RS1391425287 |
IRF2BPL
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with regression, abnormal movements |
| RS139142572 |
LCA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 5, Leber congenital amaurosis |
| RS139142865 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS1391429681 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS1391443496 |
GYS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS139145143 |
ACAD9
|
Health Risk |
Conflicting classifications of pathogenicity |
Acyl-CoA dehydrogenase 9 deficiency, Acyl-CoA dehydrogenase 9 deficiency |
| RS139145525 |
GALNT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139145929 |
CPA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, Febrile seizures |
| RS139146037 |
FGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial visceral amyloidosis, Ostertag type |
| RS139146229 |
LCAT
|
Health Risk |
Conflicting classifications of pathogenicity |
LCAT deficiency, Cardiovascular phenotype |
| RS139146525 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS139147068 |
POC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
POC1A-related disorder, POC1A-related disorder |
| RS139147487 |
EGR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, type I |
| RS1391475038 |
AP3B2
|
Health Risk |
Likely pathogenic |
— |
| RS139147641 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1391484758 |
PEX14
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, complementation group K |
| RS139148709 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS139149152 |
HSD17B3
|
Health Risk |
Conflicting classifications of pathogenicity |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS139149160 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrullinemia type II |
| RS1391492794 |
CNGB3
|
Health Risk |
Pathogenic |
Achromatopsia 3, Achromatopsia 3 |
| RS139152685 |
HSD3B7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1391527038 |
IMPDH1
|
Health Risk |
Pathogenic |
— |
| RS1391527793 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS139153235 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS139153630 |
FLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1391540245 |
CNTNAP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Inborn genetic diseases |
| RS1391542283 |
SMPD4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS139154852 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS139154868 |
GDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Telangiectasia, hereditary hemorrhagic |
| RS139154882 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS1391553153 |
SLC4A11
|
Health Risk |
Pathogenic |
— |
| RS139155515 |
UNC45A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS139155910 |
PIGO
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperphosphatasia with intellectual disability syndrome 2, Inborn genetic diseases |
| RS139156019 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS1391578014 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS139157869 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS139158008 |
CTNNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139158022 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12 |
| RS139158852 |
CLCN1
|
Health Risk |
Likely pathogenic |
Batten-Turner congenital myopathy, Batten-Turner congenital myopathy |
| RS139158921 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS139159081 |
TPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |
| RS139159095 |
IDH3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS139159258 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, LAMA2-related disorder |
| RS139159346 |
TONSL
|
Health Risk |
Likely pathogenic |
— |
| RS139159464 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Cardiomyopathy |
| RS1391596181 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS1391598284 |
NBN
|
Health Risk |
Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1391600900 |
SETBP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 29 |
| RS139160837 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS139160898 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, RAI1-related disorder |
| RS139161034 |
DUOX2
|
Health Risk |
Pathogenic |
Thyroid dyshormonogenesis 6, DUOX2-related disorder |
| RS1391614221 |
KIF7
|
Health Risk |
Pathogenic |
Acrocallosal syndrome, Acrocallosal syndrome |
| RS139161525 |
HPS6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139161723 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1391622163 |
MYH7
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1391624796 |
COL6A1
|
Health Risk |
Pathogenic |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1391625316 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Inborn genetic diseases |
| RS139163400 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS139163410 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, COL2A1-related disorder |
| RS139163545 |
GABRA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Epilepsy |
| RS139163788 |
MCM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS139163900 |
MED13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Dextro-looped transposition of the great arteries, Inborn genetic diseases |
| RS1391644554 |
LNPK
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum |